Stella Pharma Ratios and Metrics

Market cap in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 2, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Market Capitalization	11,631	25,832	13,035	9,087	11,485	17,281
Market Cap Growth	3.56%	98.17%	43.45%	-20.88%	-33.54%	-
Enterprise Value	9,554	23,927	10,396	7,501	10,146	14,767
Last Close Price	332.00	759.00	383.00	291.00	387.00	603.00
PS Ratio	36.01	79.97	13.56	33.78	50.15	172.82
PB Ratio	4.79	10.65	4.07	3.82	4.17	5.61
P/TBV Ratio	4.88	10.84	4.13	3.91	4.27	5.74
P/FCF Ratio	-	-	95.85	-	-	-
P/OCF Ratio	-	-	93.11	-	-	-
EV/Sales Ratio	29.58	74.08	10.82	27.88	44.31	147.68
EV/FCF Ratio	-27.69	-	76.44	-	-	-
Debt / Equity Ratio	0.31	0.31	0.24	0.39	0.40	0.41
Debt / FCF Ratio	-	-	5.63	-	-	-
Net Debt / Equity Ratio	-0.86	-0.86	-0.76	-0.60	-0.59	-0.66
Net Debt / EBITDA Ratio	2.88	2.88	43.57	1.96	2.10	2.86
Net Debt / FCF Ratio	6.02	6.02	-17.94	1.60	1.90	1.80
Asset Turnover	0.07	0.07	0.21	0.07	0.05	0.03
Inventory Turnover	0.04	0.04	0.10	0.05	0.03	0.03
Quick Ratio	11.16	11.16	10.05	5.34	6.58	10.69
Current Ratio	16.81	16.81	13.44	7.98	9.01	13.56
Return on Equity (ROE)	-27.69%	-27.69%	-5.01%	-29.76%	-26.68%	-46.36%
Return on Assets (ROA)	-9.45%	-9.45%	-1.22%	-11.66%	-11.14%	-13.69%
Return on Capital Employed (ROCE)	-17.70%	-17.70%	-1.80%	-22.60%	-20.60%	-16.80%
Earnings Yield	-6.71%	-3.02%	-1.07%	-8.40%	-6.77%	-4.44%
FCF Yield	-2.97%	-1.34%	1.04%	-9.75%	-7.43%	-6.52%
Buyback Yield / Dilution	-1.93%	-1.93%	-7.76%	-7.27%	-2.83%	-40.17%